Skip to main content
STAR COMBO PHARMA LIMITED logo

STAR COMBO PHARMA LIMITED — Investor Relations & Filings

Ticker · S66 ISIN · AU0000004798 ASX Manufacturing
Open in API
Filings indexed 195 across all filing types
Latest filing 2018-10-17 Investor Presentation
Country AU Australia
Listing ASX S66

About STAR COMBO PHARMA LIMITED

https://www.starcombo.com.au

Star Combo Pharma Limited specializes in the development, manufacturing, and distribution of vitamins, dietary supplements, and skincare products. The organization operates Therapeutic Goods Administration (TGA) licensed facilities, offering comprehensive Original Equipment Manufacturing (OEM) and Original Design Manufacturing (ODM) services. Its product portfolio encompasses a wide range of health and beauty solutions marketed under proprietary brands, including Costar, Living Healthy, Amax, and J&K. The company focuses on delivering premium health products to diverse markets, leveraging technical expertise in formulation and large-scale production. By maintaining rigorous quality control standards and providing end-to-end manufacturing solutions, the entity serves as a strategic partner for businesses seeking customized health and wellness products.

Recent filings

Filing Released Lang Actions
S66 Corporate Overview - Oct 2018 21 pages 1.8MB
Investor Presentation Classification · 95% confidence The document is a detailed presentation by Star Combo Pharma Ltd dated October 16, 2018, containing comprehensive financial results for the fiscal year 2018, including revenue, profit/loss, expenses, and balance sheet highlights. It also includes management profiles, company history, growth strategy, and marketing plans. The content is structured as a presentation with slides and graphics, focusing on financial performance, strategy, and market positioning. There is no indication that this is an official annual report filing (10-K) or an earnings release (ER) which typically are more concise and regulatory in nature. Instead, this document fits the description of an Investor Presentation (IP), which is a detailed presentation for investors focusing on financials, strategy, and market position. The length (15,000 characters) and detailed content support this classification with high confidence.
2018-10-17 English
Company Secretary Appointment/Resignation 1 page 66
Board/Management Information Classification · 100% confidence The document is an ASX announcement dated 10 October 2018 regarding the appointment of a new Company Secretary and joint Company Secretary. It mentions Listing Rule 3.16.1, which relates to board or management changes. The content focuses on personnel changes in senior management positions and does not contain financial data, audit information, or other report types. The document length is short (1164 characters), and it is clearly an announcement of management changes rather than a report or presentation. Therefore, the appropriate classification is Board/Management Information (MANG).
2018-10-09 English
Distributor appointed in Guangdong 1 page 67.9KB
Capital/Financing Update Classification · 90% confidence The document is an ASX announcement dated 8 October 2018 regarding the appointment of a distributor in Guangdong, China. It discusses a new distributor contract, sales channels, and market expansion but does not contain financial statements, detailed financial data, or regulatory filings. The content is an update on business operations related to distribution and market development, which fits best under Capital/Financing Update (CAP) as it relates to business expansion and potential revenue growth through new distribution channels. The document length is short and does not indicate it is a report or announcement of a report publication, so it is not RPA or RNS. Therefore, the classification is CAP with high confidence.
2018-10-07 English
2018 AGM Date and Venue 1 page 61.4KB
AGM Information Classification · 95% confidence The document is an announcement dated 4 October 2018 regarding the scheduling of the Annual General Meeting (AGM) for Star Combo Pharma Limited. It provides the date, time, and location of the AGM and mentions that the AGM notice paper and proxy form will be dispatched later. There is no detailed presentation or materials from the AGM itself, nor any financial data or results. The document is short (823 characters) and serves as a notification about the upcoming AGM rather than the AGM materials or report. Therefore, it fits the category of AGM Information (AGM-R).
2018-10-04 English
China Growth Strategy 1 page 67.3KB
Capital/Financing Update Classification · 90% confidence The document is an ASX announcement dated 12 September 2018 about the opening of a sales office in Chongqing, China, and product approvals for sale in China. It focuses on the company's growth strategy and market expansion rather than financial results, management changes, or regulatory filings. The document is short (1296 characters) and does not contain financial data, voting results, or legal information. It is a corporate update on business development activities, which fits best under Capital/Financing Update (CAP) as it relates to company growth strategy and market presence expansion.
2018-09-11 English
Investor Presentation 19 pages 1.3MB
Investor Presentation Classification · 95% confidence The document is titled 'FY 2018 Results – Investor Update Sep 2018' and contains detailed financial results for the fiscal year 2018, including revenue, gross profit, expenses, and profit/loss figures. It also includes commentary on financial performance, growth strategy, marketing overview, and company history. The document is a presentation format aimed at investors, providing a comprehensive overview of the company's financial results and strategic outlook. It is not a formal annual report (10-K) but rather an investor update presentation focusing on financials and company strategy. Therefore, it fits best under the category of Investor Presentation (IP). The document length is over 12,000 characters, indicating it is a full presentation rather than a brief announcement or summary. Hence, the classification is Investor Presentation (IP) with high confidence.
2018-09-10 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.